Genevant Sciences
Kent Chen is an accomplished scientist with extensive experience in technology development and research within the pharmaceutical and oncology sectors. Currently serving as a Scientist at Genevant Sciences since July 2021, Kent previously held the position of Research Associate at Cuprous Pharmaceuticals Inc., where formulation development and scaling-up were primary responsibilities. Kent's academic background includes a PhD in Interdisciplinary Oncology from The University of British Columbia, where research focused on copper-flavonoid complexes for acute myeloid leukemia treatment. Additional experience includes roles at BC Cancer Research Center, where lipid-based formulations were developed, and the University of British Columbia as a Biology instructor. Kent's commitment to science education is demonstrated through participation in outreach programs and internships aimed at engaging youth in science.
Genevant Sciences
Genevant is a technology-focused nucleic acid delivery company with world-class platforms, the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate and decades of expertise in nucleic acid drug development. They leverage world-class delivery systems and related technologies to bring new medicines to patients who need them. Genevant does this by selectively collaborating with leading pharma and biotech companies and fostering a culture of innovation that allows them to maintain our leadership position in the space.